Achilles Therapeutics Limited Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Achilles Therapeutics Limited is a London-based biotechnology company focused on developing AI-powered precision T cell therapies to treat solid tumors. It targets truncal (clonal) tumor neo-antigens—mutations present on all cancer cells within a patient’s tumor but not on healthy tissue—in order to direct the immune system to destroy cancer cells while limiting damage to healthy cells. The therapies are designed to be patient-specific, reflecting each tumor’s neoantigen landscape, with the aim of achieving broad coverage across cancer cells.

The company operates within the biotechnology research industry as a clinical-stage enterprise pursuing immunotherapies for solid tumors. It is based in London, England. In 2024 Achilles Therapeutics announced a research collaboration with Arcturus Therapeutics to evaluate self-amplifying mRNA personalized cancer vaccines, highlighting its engagement with partners to broaden its therapeutic approach.

Sign up for free to view info

Company overview Employee directory